CarfilzoMib IMpurity
|
|
CarfilzoMib IMpurity Eigenschaften
- Siedepunkt:
- 1077.0±65.0 °C(Predicted)
- Dichte
- 1.208±0.06 g/cm3(Predicted)
- pka
- 11.41±0.29(Predicted)
Sicherheit
CarfilzoMib IMpurity Chemische Eigenschaften,Einsatz,Produktion Methoden
CarfilzoMib IMpurity Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
CarfilzoMib IMpurity Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 15)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
ShenZhen H&D Pharmaceutical Technology Co., LTD | +8618627948422 |
sale@hdimpurity.com | China | 3389 | 58 |
Shenzhen DaerSen Science and Technology Co., Ltd. | 0755-84551027 |
China | 220 | 58 | |
Zhaoqing Wanwei New Material Technology Co., Ltd. | 0755-1328880-4488 13068786899 |
13288804488@163.com | China | 625 | 58 |
Shenzhen Popeye Biotechnology Co. Ltd. | 0755-86320212 |
popeye02@qq.com | China | 310 | 58 |
Tianjin shijia biomedical technology co., LTD | 15022261580 |
tjshj1212@163.com | China | 2520 | 58 |
Jinan blalong chemical co. LTD | 2710913286@.com |
1513643261@qq.com | China | 14246 | 58 |
Hefei fuya biotechnology co. LTD | 18096409024 |
sales02@foreversyn.com | China | 1914 | 58 |
Molcoo Chemicals Inc. | 18576690171 17386083646 |
3001006472@qq.com | China | 11837 | 58 |
Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 |
2880126944@qq.com | China | 2577 | 58 |
HX Pharmaceutical technology co., LTD | 15671363360 |
494267389@qq.com | China | 3630 | 58 |
- Kyprolis impurity
- CarfilzoMib IMpurity
- Carfilzomib Impurity YGA
- methyl ((R)-2-amino-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate
- methyl ((S)-2-amino-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate
- methyl ((R)-2-amino-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate
- methyl ((S)-2-amino-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate
- methyl ((R)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-L-phenylalaninate
- methyl ((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate
- methyl ((R)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate
- methyl ((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate
- methyl ((S)-4-phenyl-2-(2,2,2-trifluoroacetamido)butanoyl)-L-leucyl-L-phenylalaninate
- ((S)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-D-phenylalanine
- ((R)-2-(2-morpholinoacetamido)-4-phenylbutanoyl)-L-leucyl-D-phenylalanine
- (2S,2'S)-N,N'-((2S,2'S)-hydrazine-1,2-diylbis(1-oxo-3-phenylpropane-1,2-diyl))bis(4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide)
- (R)-4-Methyl-N-((S)-1-(((R)-4-Methyl-1-((S)-2-Methyloxiran-2-yl)-1-oxopentan-2-yl)aMino)-1-oxo-3-phenylpropan-2-yl)-2-((R)-2-(2-MorpholinoacetaMido)-4-phenylbutanaMido)pentanaMide
- N-(1-((1,2-dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-(2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide
- methyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate
- methyl ((S)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-D-leucyl-L-phenylalaninate
- methyl ((R)-2-((tert-butoxycarbonyl)amino)-4-phenylbutanoyl)-L-leucyl-D-phenylalaninate
- L-Phenylalaninamide, (αS)-α-[[2-(4-morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S,3R)-3-hydroxy-3-methyl-1-(2-methylpropyl)-4-[(methylsulfonyl)oxy]-2-oxobutyl]-
- Carfilzomib Impurity (S,R,S,R,R)
- 1541171-65-6